Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Mano Michael | Sep 4, 2024 | Sell | 3,971 | $0.7218 | $2,900 |
| Paulson Richard A. | Sep 4, 2024 | Sell | 3,667 | $0.7218 | $2,600 |
| Mason Michael | Sep 4, 2024 | Sell | 7,050 | $0.7218 | $5,100 |
| Cheng Sohanya Roshan | Sep 4, 2024 | Sell | 5,356 | $0.7218 | $3,900 |
| Paulson Richard A. | Aug 6, 2024 | Sell | 3,608 | $0.9299 | $3,400 |
| Poulton Stuart | Jul 30, 2024 | Sell | 2,883 | $1.06 | $3,100 |
| Paulson Richard A. | Jul 5, 2024 | Sell | 3,616 | $0.851 | $3,100 |
| PAKIANATHAN DEEPIKA | Jun 7, 2024 | Sell | 229,308 | $0.9507 | $220,000 |
| PAKIANATHAN DEEPIKA | Jun 7, 2024 | Sell | 2,240 | $0.9507 | $2,100 |
| PAKIANATHAN DEEPIKA | Jun 6, 2024 | Sell | 117,307 | $0.9828 | $120,000 |
| PAKIANATHAN DEEPIKA | Jun 6, 2024 | Sell | 1,145 | $0.9828 | $1,100 |
| PAKIANATHAN DEEPIKA | Jun 5, 2024 | Sell | 463,518 | $0.9582 | $440,000 |
| PAKIANATHAN DEEPIKA | Jun 5, 2024 | Sell | 4,526 | $0.9582 | $4,300 |
| PAKIANATHAN DEEPIKA | Jun 4, 2024 | Sell | 337,742 | $0.9521 | $320,000 |
| Paulson Richard A. | Jun 4, 2024 | Sell | 3,592 | $0.99 | $3,600 |
| PAKIANATHAN DEEPIKA | Jun 4, 2024 | Sell | 3,298 | $0.9521 | $3,100 |
| Mason Michael | Jun 4, 2024 | Sell | 652 | $0.99 | $650 |
| PAKIANATHAN DEEPIKA | Jun 3, 2024 | Sell | 357,256 | $1.0007 | $360,000 |
| PAKIANATHAN DEEPIKA | Jun 3, 2024 | Sell | 3,488 | $1.0007 | $3,500 |
| PAKIANATHAN DEEPIKA | May 31, 2024 | Sell | 202,418 | $0.954 | $190,000 |
| PAKIANATHAN DEEPIKA | May 31, 2024 | Sell | 1,976 | $0.954 | $1,900 |
| Paulson Richard A. | May 6, 2024 | Sell | 3,576 | $1.13 | $4,000 |
| Rangwala Reshma | Apr 22, 2024 | Sell | 6,789 | $1.17 | $7,900 |
| Paulson Richard A. | Apr 4, 2024 | Sell | 3,563 | $1.29 | $4,600 |
| Paulson Richard A. | Mar 5, 2024 | Sell | 3,573 | $1.3 | $4,600 |
| Paulson Richard A. | Mar 1, 2024 | Sell | 19,374 | $1.2 | $23,000 |
| Rangwala Reshma | Mar 1, 2024 | Sell | 5,969 | $1.2 | $7,200 |
| Poulton Stuart | Mar 1, 2024 | Sell | 6,155 | $1.2 | $7,400 |
| Mason Michael | Mar 1, 2024 | Sell | 6,162 | $1.2 | $7,400 |
| Mano Michael | Mar 1, 2024 | Sell | 3,576 | $1.2 | $4,300 |
| Cheng Sohanya Roshan | Mar 1, 2024 | Sell | 5,109 | $1.2 | $6,100 |
| Rangwala Reshma | Feb 29, 2024 | Sell | 15,667 | $1.17 | $18,000 |
| Poulton Stuart | Feb 29, 2024 | Sell | 16,311 | $1.17 | $19,000 |
| Mason Michael | Feb 29, 2024 | Sell | 27,687 | $1.17 | $32,000 |
| Mano Michael | Feb 29, 2024 | Sell | 16,973 | $1.17 | $20,000 |
| Cheng Sohanya Roshan | Feb 29, 2024 | Sell | 21,840 | $1.17 | $26,000 |
| Paulson Richard A. | Feb 29, 2024 | Sell | 80,470 | $1.17 | $94,000 |
| Mason Michael | Feb 27, 2024 | Sell | 2,545 | $1.3238 | $3,400 |
| Poulton Stuart | Feb 15, 2024 | Sell | 5,748 | $1.33 | $7,600 |
| Poulton Stuart | Feb 15, 2024 | Sell | 99 | $1.4 | $140 |
| Mason Michael | Feb 6, 2024 | Sell | 4,205 | $1.5865 | $6,700 |
| Paulson Richard A. | Feb 6, 2024 | Sell | 4,012 | $1.5865 | $6,400 |
| Paulson Richard A. | Jan 4, 2024 | Sell | 4,114 | $0.82 | $3,400 |
| Paulson Richard A. | Dec 4, 2023 | Sell | 3,622 | $0.79 | $2,900 |
| Paulson Richard A. | Nov 6, 2023 | Sell | 3,606 | $0.9203 | $3,300 |
| Paulson Richard A. | Oct 4, 2023 | Sell | 3,589 | $1.27 | $4,600 |
| BOHLIN GAREN G | Sep 12, 2023 | Buy | 41,140 | $1.215 | $50,000 |
| Paulson Richard A. | Sep 5, 2023 | Sell | 3,558 | $1.33 | $4,700 |
| Paulson Richard A. | Sep 5, 2023 | Sell | 64 | $1.32 | $84 |
| Mason Michael | Sep 1, 2023 | Sell | 6,913 | $1.3313 | $9,200 |
| Mano Michael | Sep 1, 2023 | Sell | 3,888 | $1.3313 | $5,200 |
| Cheng Sohanya Roshan | Sep 1, 2023 | Sell | 7,415 | $1.3313 | $9,900 |
| Paulson Richard A. | Aug 7, 2023 | Sell | 3,722 | $1.72 | $6,400 |
| Poulton Stuart | Jul 28, 2023 | Sell | 2,845 | $1.7 | $4,800 |
| Paulson Richard A. | Jul 5, 2023 | Sell | 3,538 | $1.72 | $6,100 |
| Cheng Sohanya Roshan | Jun 8, 2023 | Sell | 1,839 | $2.35 | $4,300 |
| Paulson Richard A. | Jun 5, 2023 | Sell | 3,536 | $2.2404 | $7,900 |
| Mason Michael | Jun 2, 2023 | Sell | 631 | $2.22 | $1,400 |
| Paulson Richard A. | May 4, 2023 | Sell | 3,805 | $3.3516 | $13,000 |
| Rangwala Reshma | Apr 20, 2023 | Sell | 6,655 | $4.05 | $27,000 |
| Rangwala Reshma | Apr 20, 2023 | Sell | 115 | $4.0267 | $460 |
| Paulson Richard A. | Apr 4, 2023 | Sell | 3,497 | $3.97 | $14,000 |
| Paulson Richard A. | Mar 6, 2023 | Sell | 3,506 | $3.16 | $11,000 |
| Cheng Sohanya Roshan | Mar 1, 2023 | Sell | 11,239 | $3.0292 | $34,000 |
| Mason Michael | Mar 1, 2023 | Sell | 11,205 | $3.0292 | $34,000 |
| Paulson Richard A. | Mar 1, 2023 | Sell | 33,033 | $3.0292 | $100,000 |
| Mitchener Stephen | Mar 1, 2023 | Sell | 6,357 | $3.0292 | $19,000 |
| Mano Michael | Mar 1, 2023 | Sell | 6,878 | $3.0292 | $21,000 |
| Mason Michael | Feb 27, 2023 | Sell | 2,802 | $3.0368 | $8,500 |
| Poulton Stuart | Feb 15, 2023 | Sell | 5,665 | $3.19 | $18,000 |
| Poulton Stuart | Feb 15, 2023 | Sell | 196 | $3.16 | $620 |
| Poulton Stuart | Feb 15, 2023 | Sell | 8 | $3.23 | $26 |
| Mason Michael | Feb 6, 2023 | Sell | 4,141 | $3.4 | $14,000 |
| Paulson Richard A. | Feb 6, 2023 | Sell | 3,950 | $3.4 | $13,000 |
| Paulson Richard A. | Jan 4, 2023 | Sell | 3,922 | $3.27 | $13,000 |
| Paulson Richard A. | Dec 5, 2022 | Sell | 3,490 | $5.17 | $18,000 |
What's the latest insider transaction for Karyopharm Therapeutics?
The most recent insider transaction for Karyopharm Therapeutics was conducted by Mano Michael, who sold 3,971 shares on September 4, 2024 at a price of $0.72 per share.
Which insider bought the most KPTI stock over the last two years?
BOHLIN GAREN G has bought the most KPTI stock in the last 2 years, with a total value of $50,000.
Which insider has sold the most KPTI stock over the last two years?
PAKIANATHAN DEEPIKA has sold the most KPTI stock in the last 2 years, with a total value of $1.7M.
What is the total value of insider transactions for Karyopharm Therapeutics (KPTI) in the last 2 years?
The total value of insider transactions for Karyopharm Therapeutics in the last 2 years is negative, amounting to -$2.4M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Karyopharm Therapeutics' market confidence?
Over the last 2 years, insider transactions for Karyopharm Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
